Provide the world pharmaceutical partners “StackDoseTM new drug development technology solutions”, enabling pharmaceutical companies to produce new dosage forms with precise time-controlled dissolution, precise site absorption, and various dosage adjustments, which can not only improve the bioavailability of active pharmaceutical ingredients to achieve the best effect, but also reduce the dosage of drugs, thus reducing side effects.
The adoption of Merdury's developed of 3D powder printing molding patent technology, and powder and binder formulation（powder and bio-adhesive formulation）. After Set the configuration and structure of API and excipients optimized through computer calculations, then start printing.First coat on the platform with a layer of API powder by precisely dosage. Then coat a adhesive by printhead to bind the powder together. Repeats The process layer by layer until the drug complete to be formed. This technology can achieved by changing the ordinal tablet form（such as swallowing tablets to OTD or sublingual tablets）, thereby reducing the dosage of drugs used and thereby reducing side effects.In addition, Multiple main component compound drug（more than one APIs into one dose） can be produce by our Multiple component process technology, to reduce the number of drugs swallowed by patiets and increase their compliance with the drugs.
Unlike most traditional pharmaceutical manufacturing methods, the three key technologies of the “StackDoseTM new drug technology development platform” are:
Based on the properties of the API (powder or liquid form) and the desired formulation. Select suitable excipients and formulate according to the equipment compatibility for drug development. We can develop multiple dosage form and properties of the drugs:
The drug production process (from powder dispensing, shaping, tablet retrieval, to sieving) is integrated into a single device. It offers automated production, adaptable production conditions (temperature/humidity/yield), and precise dosing. The key automated production processes include:
Featuring an intuitive user interface coupled with a large touchscreen, it provides real-time display of various data related to drug production status. It also allows for live viewing of actual production status within the facility.
By employing more precise and flexible development techniques, we elevate the technological thresholds for our pharmaceutical partners, maximizing the market value of the drugs.
Development of various special formulation drugs (single or composite API, rapid disintegration or extended release, dosage).
requirements of different production condition of drugs (production environment, capacity, structure, appearance).
Cost Reducing drug development time, lowering development costs and risks.
Integrated solutions that save space and eliminate the complexity of operating multiple devices.
24hr comprehensive monitoring of production status, data recording, and remote troubleshooting.
Automatic cleaning of production equipment, to save energy and increased operation efficiency.
